Radiotherapy Market worth $10.68 billion by 2031 | MarketsandMarkets™
DELRAY BEACH, Fla., June 3, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Radiotherapy Market is projected to grow from about USD 7.98 billion in 2026 to USD 10.68 billion by 2031, at a CAGR of 6.0%.
Browse 304 market data Tables and 56 Figures spread through 320 Pages and in-depth TOC on "Radiotherapy Market - Global Forecast to 2031"
Radiotherapy Market Size & Forecast:
- Market Size Available for Years: 2025–2031
- 2026 Market Size: USD 7.98 billion
- 2031 Projected Market Size: USD 10.68 billion
- CAGR (2026–2031): 6.0%
Radiotherapy Market Trends & Insights:
- By offering, the systems segment accounted for the largest market share of 55.5% in 2025.
- By technology, the external beam radiotherapy segment is expected to register the highest CAGR of 5.7% during the forecast period.
- By application, the EBRT applications segment dominated the market with a share of 96.0% in 2025.
- The Asia Pacific is projected to witness the highest CAGR of 7.1% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567
Due to high demand from various customers, industry participants have placed significant focus on manufacturing affordable radiotherapy equipment. The need for radiotherapy, particularly external beam radiation therapy (EBRT), is increasing in emerging markets. This growth can be attributed to improved reimbursement policies, higher per-capita healthcare spending, and growing demand for cost-effective cancer treatment. According to World Bank data, healthcare spending is projected to grow at an annual rate of 5–6% through 2030, driven by demand for advanced technologies such as linear accelerators, particle radiotherapy, and proton therapy for breast and other cancers. Furthermore, investments in the health sector in emerging nations such as Brazil, India, and South Africa are expected to grow by more than 7% annually.
The system segment is to register a significant growth rate over the forecast period of 2024-2030.
Based on the system, software & services, over the forecast period of 2024-2030, the system segment is to register a significant growth rate. The radiotherapy product market is segmented into system and the software & services. The radiotherapy 'system' market includes system, consumables, probes, and applicators used to deliver radiotherapy through external beam radiation therapy and brachytherapy. The key factors encouraging the growth of system segment during the forecast period are the increased adoption of radiotherapy in emerging economies and the rising number of manufacturers offering advanced systems.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=567
The industrial manufacturing segment accounted for the largest share of radiotherapy in 2024-2030.
Based on application, during the forecast period, the external beam radiotherapy (EBRT) segment is anticipated to dominate the radiotherapy market, holding the largest market share. The external beam radiotherapy segment commands a significant share due to the increasing research activities to study the application and rising demand for radiotherapy products across key markets (such as the US, Europe, China, India, and the Middle East).
Asia Pacific registered the highest CAGR in the market during the forecast period.
In 2024, Asia Pacific is expected to register the highest CAGR in the market for radiotherapy during the forecast period. Asia Pacific comprises China, India, South Korea, Taiwan, and Singapore, and the rest of Asia Pacific. Factors such as increasing cancer prevalence, an aging demographic, and improving healthcare infrastructure are driving the growth of this region. Government policy support, a rise in investment, and technological breakthroughs also help drive this expansion. Additionally, the growth of medical tourism in emerging economies such as India and the presence of prominent players are influencing higher demand for radiotherapy solutions. For instance, in August 2023, BEBIG Medical (Germany) allied with Shinva Medical Instrument (China) to further strengthen its position in the LINAC sector.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=567
Top Companies in Radiotherapy Market:
The Top Companies in Radiotherapy Market include Siemens Healthineers GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA WORLDWIDE (Belgium), ViewRay Technologies, Inc (US), Perspective Therapeutics, Inc. (US), Hitachi High Tech Corporation (Japan), Sumitomo Heavy Industries Ltd. (Japan), Carl Zeiss Meditec AG (Germany) and Koninklijke Philips N.V. (Netherlands), among others.
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Related Reports:
Radiation Dose Management Market - Global Forecast to 2028
Particle Therapy Market - Global Forecast to 2028
Medical Radiation Detection Market - Global Forecast to 2029
Advanced Visualization Market - Global Forecast to 2029
CT Simulators Market - Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg
SOURCE MarketsandMarkets
Share this article